Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Enhancing SDS-PAGE with the Prestained Protein Marker: Tripl
2026-06-17
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) from APExBIO delivers clear, multi-color banding for effortless protein size verification and transfer efficiency monitoring. Its EDTA-free formulation unlocks advanced workflows—like Phosbind SDS-PAGE and fluorescent imaging—making it indispensable for translational research and troubleshooting complex resistance mechanisms.
-
DMG-PEG2000-NH2: Optimizing Liposomal Drug Delivery Workflow
2026-06-17
DMG-PEG2000-NH2, an NH2-PEG derivative from APExBIO, enables robust, reproducible amide bond formation for lipid-based drug delivery. This guide dissects best-practice experimental workflows, troubleshooting, and next-generation applications, streamlining siRNA encapsulation and nanoparticle formulation.
-
CRISPRi Targeting of Fabp4 in Adipocytes: Impacts on Obesity
2026-06-16
This study introduces a targeted, nonviral CRISPR interference system to selectively silence Fabp4 in white adipocytes, resulting in significant improvements in obesity-related pathologies and hepatic steatosis. The approach demonstrates the translational potential of precision gene modulation for metabolic and liver disease research.
-
Cy5 TSA Fluorescence System Kit: Next-Level Signal Amplifica
2026-06-16
Unlock 100-fold sensitivity gains in immunohistochemistry, FISH, and ICC with the Cy5 TSA Fluorescence System Kit. Discover proven workflows, troubleshooting insights, and how this kit uniquely empowers detection of low-abundance targets in cancer and spatial biology research.
-
ML-7 Hydrochloride: Precision Myosin Light Chain Kinase Inhi
2026-06-15
ML-7 hydrochloride is a benchmark myosin light chain kinase inhibitor empowering cardiovascular and vascular research with high selectivity and reproducibility. See how this tool optimizes ischemia/reperfusion injury and endothelial dysfunction models, with actionable protocol insights and troubleshooting for robust, translational results.
-
Cyclosporin A (B1922): Technical Guide for Experimental Use
2026-06-15
Cyclosporin A is a potent immunosuppressive agent essential for dissecting T-cell signaling, apoptosis, and viral mechanisms in cell and animal research models. It is best suited for workflows requiring precise cyclophilin or calcineurin-NFAT inhibition, but should not be used where aqueous solubility or prolonged solution stability is necessary.
-
Dacarbazine: Mechanisms, Strategy, and Next-Gen Translationa
2026-06-14
Explore the dual mechanistic and strategic landscape of Dacarbazine—a cornerstone antineoplastic chemotherapy drug. This thought-leadership article unpacks the molecular rationale, translational validation, and evolving clinical paradigms in malignant melanoma, Hodgkin lymphoma, and sarcoma. Expertly blending recent advances in in vitro models and clinical evidence, it guides researchers toward optimizing DNA damage therapies and integrating breakthrough antiemetic strategies.
-
SM-102 for mRNA Delivery: Protocols, Pitfalls, and Innovatio
2026-06-13
SM-102’s unique lipid chemistry powers next-generation mRNA vaccine delivery, as proven in advanced localized therapies for bladder cancer. Discover actionable protocol refinements, troubleshooting strategies, and data-driven insights that put SM-102 at the forefront of clinical and translational mRNA applications.
-
S Tag Peptide (A6007): Technical Guide for Fusion Tag Workfl
2026-06-12
S Tag Peptide (SKU A6007) addresses challenges in recombinant protein detection, purification, and solubility by providing a short, highly soluble fusion tag compatible with antibody-based workflows. Researchers should avoid ethanol-based systems and long-term aqueous storage due to solubility and stability constraints. Use this peptide for applications requiring reliable detection or improved handling of recombinant proteins.
-
Cell Divisions Refine and Challenge Tissue Boundaries in Dro
2026-06-12
This study reveals that cell divisions in the Drosophila embryo both destabilize and sharpen tissue boundaries by modulating tissue fluidity and mechanical tension. The findings deepen our mechanistic understanding of morphogenesis and have implications for research into developmental biology and disease.
-
Isoproterenol Sulfate Dihydrate in Human Cardiac Assembloid
2026-06-11
Isoproterenol sulfate dihydrate (APExBIO C6402) empowers highly reproducible, data-rich modeling of beta-adrenergic signaling in advanced human cardiac assembloid systems. This article decodes protocol enhancements, troubleshooting strategies, and practical workflow adaptations for researchers probing neuro-cardiac dynamics and pacemaker maturation.
-
Evaluating In Vitro Drug Responses in Cancer: Innovation in
2026-06-11
Schwartz's dissertation advances in vitro evaluation of anti-cancer drugs by dissecting the nuanced relationship between growth inhibition and cell death, showing these are distinct yet overlapping outcomes. These insights refine how angiogenesis inhibition assays and tumor model studies can interpret drug efficacy, with implications for experimental design and translational research.
-
Ferroptosis and NRF2 Pathway in FDXR-Related Disease Mechani
2026-06-10
This study reveals ferroptosis as a pathogenic mechanism in FDXR-related mitochondrial disease, driven by disruption of the NRF2 antioxidant pathway. The findings highlight the importance of iron metabolism and oxidative stress in disease progression and suggest therapeutic targets involving NRF2 activation and iron-chelating strategies.
-
Docetaxel in Cancer Research: Protocols, Performance & Pitfa
2026-06-10
Docetaxel (Taxotere) stands out as a gold-standard microtubule stabilizer for apoptosis and chemoresistance studies in diverse cancer models. This article delivers actionable guidance on experimental design, troubleshooting, and leveraging the latest insights from prostate and ovarian cancer research to maximize reproducibility and translational impact.
-
Safe DNA Gel Stain: Optimizing Sensitive DNA and RNA Gel Sta
2026-06-09
Safe DNA Gel Stain offers a safer, high-sensitivity alternative to ethidium bromide for DNA and RNA visualization. Its compatibility with blue-light excitation reduces DNA damage and boosts cloning efficiency, setting a new standard for molecular biology workflows.